plasmid mediated extended spectrum beta-lactamases (ESBLs), which are class A enzymes and derivative of beta-lactamases (TEM & SHV beta-lactamases) which have undergone one or more amino acid substitutions near the active site of enzyme. 1, 4 The ESBLs producing organisms are reported worldwide in increasing numbers for which Clinical Laboratory Standard Institute (CLSI) recommends screening for ESBLs producing Klebsiella species, where the clinical microbiological tests are used to detect ESBLs and employ a beta-lactamase inhibitor usually clavulanate in combination with cephalosporins (e.g. ceftazidime + clavulanate) in which clavulanate inhibits ESBLs reducing the level of resistance to cephalosporins and thereby increasing the zone of inhibition. 5 This study was undertaken to determine the detection and prevalence of ESBLs producing Klebsiella species in various clinical specimens received from Government Wenlock Hospital and Lady Goschen Hospital Mangalore, by using the combined disc method, according to guidelines of CLSI .
Materials and methods
The study was conducted at the Department of Microbiology, KMC Mangalore where the various clinical specimens like urine, sputum, pus, wound swabs, blood and other body fluids were received from the indoor patients of Government Wenlock Hospital and Lady Goshen Hospital, Mangalore.
A total of 280 gram negative bacterial isolates obtained over a period of one year from 1 st January 2007 to 31 st December 2007 were identified based on standard microbiological methods. 6 Among these, 60 isolates were identified as Klebsiella species and antimicrobial susceptibility was performed by using Kirby-Bauer disc-diffusion method, as per NCCLS guidelines, 7 where the following antibiotics (from Himedia, Mumbai, India) were taken: Imipenem (10µg), Cefotaxime (30µg), Cefoxitin (30µg), Ceftazidime (30µg), Ceftazidime + Clavulanic acid (30/ 10µg), Aztreonam (30µg), and Cefpodoxime (10µg). The test inocula were matched with 0.5 Mc Farland turbidity standard and lawn cultured onto the Mueller Hinton agar plates (from Himedia, Mumbai, India).The disc placement was designed in novel fashion to detect ESBL production. 8, 9, 10 The discs of ceftazidime and ceftazidime + clavulanic acid were kept 15mm apart from each other (centre to centre). Imipenem disc, an inducer was placed in center and on either side of it at 15mm distance, ceftazidime and cefotaxime (indicator of induction ) were placed. In addition, another inducer cefoxitin was placed 15mm from cefotaxime (indicator). This was placed opposite to that of ceftazidime + clavulanic acid to avoid any affect of inducible beta lactamase on the zone of inhibition of the latter. 8 The remaining discs were placed as shown in the figure A: The agar plates were incubated at 37ÚC for 18 to 24 hours.
9, 10
The following criteria have been used to decide organisms to be ESBL producers. 
Antibiotic susceptibility of Klebsiella spp to detect
ESBL production.
Discussion
Beta lactamases continue to be the leading cause of resistance to beta-lactam antibiotics in gram negative bacilli. In recent years there has been an increased incidence and prevalence of ESBLs that hydrolyze and cause resistance to oxymino-cephalosporins and aztreonam. 13 For a number of reasons, the detection of ESBL-producing strains is of significant importance for all major hospitals worldwide. First, these strains are most likely to be even more prevalent than it is currently recognized. Due to the difficulty in their detection by the current clinical methods, many of these strains have been reported to be susceptible to widely used and tested broad-spectrum ß-lactams.
Secondly, ESBLs constitute a serious threat to current 
